CommercialCoverageMedium impact
11.06.10a, Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis
Independence Blue Cross·OB-GYN·Medical Policy
Effective date
Jun 24, 2026
We identified it
Jun 25, 2026
Summary
Policy 11.06.10a regarding laparoscopic, percutaneous, and transcervical techniques for uterine fibroid myolysis has been reissued effective 06/24/2026. This is a commercial policy update that billing teams must review for any changes to coverage criteria, prior authorization requirements, or billing code guidance for fibroid treatment procedures.
Action Required
By 06/24/2026: Billing team must obtain and review the complete policy text at the source URL to identify specific CPT/HCPCS codes affected, prior authorization requirements, and coverage criteria for laparoscopic, percutaneous, and transcervical uterine fibroid procedures. Update billing system rules, prior authorization workflows, and provider education materials accordingly. Contact the policy source (IBX) if the full policy text is not accessible. Failure to implement required changes by the effective date may result in claim denials or improper reimbursement.